(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Chris A Raanes \u0010President/CEO \u0010Viewray Inc \u0010Will discuss the rollout of their cancer treatment, MRIdian, which can both image, and treat cancer patients at the same time.

Nvidia to Invest $3.5 Billion in Chipmaker MediaTek
22:06

Warsh Says Inflation Isn’t Slowing, Vows to Reach 2% Target
15:10

Salesforce Jumps Most Since 2020 on Outlook, Anthropic Deal
21:35